tesaglitazar has been researched along with scopolamine hydrobromide in 2 studies
Studies (tesaglitazar) | Trials (tesaglitazar) | Recent Studies (post-2010) (tesaglitazar) | Studies (scopolamine hydrobromide) | Trials (scopolamine hydrobromide) | Recent Studies (post-2010) (scopolamine hydrobromide) |
---|---|---|---|---|---|
74 | 13 | 25 | 7,548 | 563 | 1,401 |
Protein | Taxonomy | tesaglitazar (IC50) | scopolamine hydrobromide (IC50) |
---|---|---|---|
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.003 | |
Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.006 | |
Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.006 | |
Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.006 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.0006 | |
Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.006 | |
Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.006 | |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0026 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
2 other study(ies) available for tesaglitazar and scopolamine hydrobromide
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |